| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.938 | 0.001 | 0.938 | Alpha-N-acetylglucosaminidase inhibitor | 0.706 0.003 DBMET01478 | ||
| 0.926 | 0.003 | 0.926 | Hypoglycemic | 0.702 0.005 DBMET01478 | ||
| 0.893 | 0.002 | 0.893 | Alcohol oxidase inhibitor | 0.153 0.01 DBMET01478 | ||
| 0.803 | 0.004 | 0.803 | Immunomodulator | 0.782 0.005 DBMET01478 | ||
| 0.796 | 0.001 | 0.945 | Triose-phosphate isomerase inhibitor | 0.945 0 DBMET01478 | DBMET01478 | |
| 0.77 | 0.002 | 0.77 | Amylase inhibitor | 0.387 0.01 DBMET01478 | ||
| 0.701 | 0.014 | 0.701 | Cyclophilin D inhibitor | 0.358 0.117 DBMET01478 | ||
| 0.655 | 0.012 | 0.655 | Aldehyde oxidase inhibitor | |||
| 0.629 | 0.001 | 0.875 | Phosphofructokinase-1 inhibitor | 0.875 0 DBMET01478 | DBMET01478 | |
| 0.591 | 0.001 | 0.663 | UDP-glucose 4-epimerase inhibitor | 0.663 0.001 DBMET01478 | DBMET01478 | |
| 0.615 | 0.049 | 0.615 | Antiinflammatory | 0.436 0.118 DBMET01478 | ||
| 0.549 | 0.001 | 0.549 | Alpha-mannosidase inhibitor | 0.212 0.003 DBMET01478 | ||
| 0.536 | 0.001 | 0.536 | Mannosidase inhibitor | 0.188 0.003 DBMET01478 | ||
| 0.537 | 0.004 | 0.65 | Aldehyde dehydrogenase inhibitor | 0.65 0.003 DBMET01478 | DBMET01478 | |
| 0.513 | 0.002 | 0.978 | Mannose-6-phosphate isomerase inhibitor | 0.978 0.001 DBMET01478 | DBMET01478 | |
| 0.486 | 0.001 | 0.689 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.689 0 DBMET01478 | DBMET01478 | |
| 0.49 | 0.014 | 0.66 | DNA synthesis inhibitor | 0.66 0.005 DBMET01478 | DBMET01478 | |
| 0.442 | 0 | 0.847 | Glucose-6-phosphate isomerase inhibitor | 0.847 0 DBMET01478 | DBMET01478 | |
| 0.48 | 0.039 | 0.621 | Immunosuppressant | 0.621 0.011 DBMET01478 | DBMET01478 | |
| 0.442 | 0.004 | 0.442 | Succinate dehydrogenase inhibitor | 0.215 0.038 DBMET01478 | ||
| 0.438 | 0.004 | 0.677 | Hexokinase inhibitor | 0.677 0.002 DBMET01478 | DBMET01478 | |
| 0.437 | 0.004 | 0.653 | NADH dehydrogenase inhibitor | 0.653 0.001 DBMET01478 | DBMET01478 | |
| 0.437 | 0.005 | 0.437 | Interleukin 6 antagonist | 0.284 0.017 DBMET01478 | ||
| 0.508 | 0.078 | 0.508 | Alpha-glucosidase inhibitor | |||
| 0.467 | 0.044 | 0.467 | 5 Hydroxytryptamine release inhibitor | |||
| 0.422 | 0 | 0.474 | Mannitol 2-dehydrogenase inhibitor | 0.474 0 DBMET01478 | DBMET01478 | |
| 0.417 | 0.018 | 0.417 | Peroxidase inhibitor | |||
| 0.45 | 0.057 | 0.504 | Antibacterial | 0.504 0.039 DBMET01478 | DBMET01478 | |
| 0.412 | 0.025 | 0.412 | Superoxide dismutase inhibitor | |||
| 0.382 | 0.004 | 0.544 | Adenylate kinase inhibitor | 0.544 0.001 DBMET01478 | DBMET01478 | |
| 0.421 | 0.044 | 0.589 | Immunostimulant | 0.589 0.018 DBMET01478 | DBMET01478 | |
| 0.417 | 0.067 | 0.417 | Histamine release inhibitor | |||
| 0.355 | 0.009 | 0.45 | Alkylator | 0.45 0.006 DBMET01478 | DBMET01478 | |
| 0.349 | 0.008 | 0.362 | Chelator | 0.362 0.007 DBMET01478 | DBMET01478 | |
| 0.36 | 0.03 | 0.735 | Pyruvate kinase inhibitor | 0.735 0.003 DBMET01478 | DBMET01478 | |
| 0.374 | 0.045 | 0.374 | Vasodilator, coronary | 0.204 0.178 DBMET01478 | ||
| 0.382 | 0.053 | 0.382 | Cholesterol antagonist | |||
| 0.344 | 0.02 | 0.344 | Hepatoprotectant | 0.227 0.051 DBMET01478 | ||
| 0.382 | 0.073 | 0.382 | Antiobesity | |||
| 0.411 | 0.104 | 0.418 | Caspase 9 stimulant | 0.418 0.101 DBMET01478 | DBMET01478 | |
| 0.275 | 0.004 | 0.612 | Phosphorylase inhibitor | 0.612 0.002 DBMET01478 | DBMET01478 | |
| 0.268 | 0.007 | 0.268 | Catalase inhibitor | 0.099 0.039 DBMET01478 | ||
| 0.264 | 0.004 | 0.264 | Glutamate decarboxylase inhibitor | 0.157 0.012 DBMET01478 | ||
| 0.257 | 0.003 | 0.257 | Factor V inhibitor | 0.196 0.005 DBMET01478 | ||
| 0.322 | 0.076 | 0.573 | Antithrombotic | 0.573 0.019 DBMET01478 | DBMET01478 | |
| 0.246 | 0.005 | 0.246 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.265 | 0.025 | 0.265 | Growth factor agonist | |||
| 0.24 | 0.004 | 0.24 | Neuraminidase (influenza) inhibitor | |||
| 0.235 | 0.002 | 0.235 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.031 0.005 DBMET01478 | ||
| 0.236 | 0.004 | 0.517 | Biliverdin reductase inhibitor | 0.517 0.001 DBMET01478 | DBMET01478 | |
| 0.234 | 0.006 | 0.46 | Carbamoyl phosphate synthetase inhibitor | 0.46 0.003 DBMET01478 | DBMET01478 | |
| 0.239 | 0.011 | 0.392 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.392 0.004 DBMET01478 | DBMET01478 | |
| 0.239 | 0.012 | 0.239 | Microtubule formation inhibitor | 0.171 0.028 DBMET01478 | ||
| 0.263 | 0.042 | 0.263 | Peptidyltransferase inhibitor | |||
| 0.229 | 0.009 | 0.229 | Mucolytic | 0.201 0.013 DBMET01478 | ||
| 0.232 | 0.015 | 0.232 | Expectorant | 0.23 0.015 DBMET01478 | ||
| 0.216 | 0.003 | 0.216 | Glucosylceramidase inhibitor | |||
| 0.214 | 0.004 | 0.214 | Neuraminidase inhibitor | |||
| 0.207 | 0.007 | 0.423 | Ornithine carbamoyltransferase inhibitor | 0.423 0.003 DBMET01478 | DBMET01478 | |
| 0.208 | 0.018 | 0.208 | Interleukin 1b antagonist | |||
| 0.207 | 0.02 | 0.207 | Aminopeptidase B inhibitor | 0.154 0.036 DBMET01478 | ||
| 0.216 | 0.035 | 0.216 | Melanin inhibitor | 0.173 0.056 DBMET01478 | ||
| 0.183 | 0.005 | 0.183 | 3C-Like protease (SARS coronavirus) inhibitor | 0.16 0.007 DBMET01478 | ||
| 0.261 | 0.084 | 0.261 | 5 Hydroxytryptamine release stimulant | |||
| 0.197 | 0.021 | 0.197 | GABA C receptor agonist | |||
| 0.187 | 0.012 | 0.313 | Sphingomyelinase inhibitor | 0.313 0.003 DBMET01478 | DBMET01478 | |
| 0.242 | 0.071 | 0.283 | Hypolipemic | 0.283 0.054 DBMET01478 | DBMET01478 | |
| 0.225 | 0.054 | 0.225 | Nitric-oxide synthase stimulant | |||
| 0.276 | 0.11 | 0.276 | Vasodilator, peripheral | |||
| 0.199 | 0.034 | 0.217 | Arachidonic acid antagonist | 0.217 0.019 DBMET01478 | DBMET01478 | |
| 0.186 | 0.03 | 0.311 | Cholesterol synthesis inhibitor | 0.311 0.01 DBMET01478 | DBMET01478 | |
| 0.172 | 0.016 | 0.22 | Alcohol dehydrogenase inhibitor | 0.22 0.01 DBMET01478 | DBMET01478 | |
| 0.162 | 0.008 | 0.259 | Acyl-CoA dehydrogenase inhibitor | 0.259 0.003 DBMET01478 | DBMET01478 | |
| 0.242 | 0.088 | 0.242 | Antioxidant | |||
| 0.266 | 0.112 | 0.352 | Apoptosis antagonist | 0.352 0.055 DBMET01478 | DBMET01478 | |
| 0.165 | 0.013 | 0.277 | Hematopoietic | 0.277 0.005 DBMET01478 | DBMET01478 | |
| 0.167 | 0.016 | 0.167 | Ca2+-transporting ATPase inhibitor | |||
| 0.165 | 0.014 | 0.435 | Glutamate dehydrogenase inhibitor | 0.435 0.004 DBMET01478 | DBMET01478 | |
| 0.171 | 0.022 | 0.171 | Protease inhibitor | 0.101 0.064 DBMET01478 | ||
| 0.176 | 0.029 | 0.176 | Adenylate cyclase stimulant | 0.174 0.031 DBMET01478 | ||
| 0.156 | 0.011 | 0.33 | Argininosuccinate synthase inhibitor | 0.33 0.003 DBMET01478 | DBMET01478 | |
| 0.324 | 0.182 | 0.324 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.167 | 0.027 | 0.167 | Antineoplastic antibiotic | 0.075 0.061 DBMET01478 | ||
| 0.226 | 0.095 | 0.226 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.173 | 0.045 | 0.187 | Cell wall synthesis inhibitor | 0.187 0.036 DBMET01478 | DBMET01478 | |
| 0.211 | 0.084 | 0.503 | RNA-directed DNA polymerase inhibitor | 0.503 0.011 DBMET01478 | DBMET01478 | |
| 0.138 | 0.012 | 0.138 | Interferon agonist | 0.115 0.019 DBMET01478 | ||
| 0.265 | 0.141 | 0.265 | GABA C receptor rho-3 antagonist | |||
| 0.139 | 0.015 | 0.139 | Aminopeptidase I inhibitor | 0.099 0.028 DBMET01478 | ||
| 0.182 | 0.058 | 0.565 | Phospholipase C inhibitor | 0.565 0.004 DBMET01478 | DBMET01478 | |
| 0.137 | 0.02 | 0.137 | Selectin antagonist | |||
| 0.158 | 0.041 | 0.158 | Cathepsin H inhibitor | |||
| 0.152 | 0.037 | 0.152 | Ferrochelatase inhibitor | |||
| 0.118 | 0.003 | 0.118 | Plasmepsin I inhibitor | 0.051 0.007 DBMET01478 | ||
| 0.12 | 0.006 | 0.12 | Aconitate hydratase inhibitor | 0.049 0.041 DBMET01478 | ||
| 0.186 | 0.073 | 0.186 | Nitric oxide antagonist | |||
| 0.176 | 0.063 | 0.176 | ATPase inhibitor | |||
| 0.158 | 0.047 | 0.275 | Toll-Like receptor 2 antagonist | 0.275 0.006 DBMET01478 | DBMET01478 | |
| 0.203 | 0.102 | 0.234 | Vasodilator | 0.234 0.079 DBMET01478 | DBMET01478 | |
| 0.133 | 0.032 | 0.133 | Creatine kinase inhibitor | |||
| 0.11 | 0.011 | 0.11 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 DBMET01478 | ||
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.096 0.035 DBMET01478 | ||
| 0.122 | 0.025 | 0.318 | Histidine decarboxylase inhibitor | 0.318 0.005 DBMET01478 | DBMET01478 | |
| 0.098 | 0.004 | 0.098 | Neuraminidase (Influenza A) inhibitor | |||
| 0.099 | 0.006 | 0.099 | Adenosine deaminase inhibitor | 0.081 0.009 DBMET01478 | ||
| 0.133 | 0.041 | 0.133 | GABA C receptor antagonist | 0.128 0.045 DBMET01478 | ||
| 0.115 | 0.023 | 0.156 | Keratolytic | 0.156 0.013 DBMET01478 | DBMET01478 | |
| 0.158 | 0.068 | 0.158 | Interferon gamma antagonist | |||
| 0.104 | 0.015 | 0.104 | Maillard reaction inhibitor | |||
| 0.12 | 0.04 | 0.12 | GABA C receptor rho-1 antagonist | 0.094 0.072 DBMET01478 | ||
| 0.173 | 0.092 | 0.434 | Anesthetic general | 0.434 0.013 DBMET01478 | DBMET01478 | |
| 0.112 | 0.032 | 0.137 | Ornithine decarboxylase inhibitor | 0.137 0.015 DBMET01478 | DBMET01478 | |
| 0.2 | 0.121 | 0.2 | Interleukin agonist | 0.198 0.122 DBMET01478 | ||
| 0.116 | 0.039 | 0.116 | MAP kinase kinase 1 inhibitor | |||
| 0.16 | 0.086 | 0.16 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.134 | 0.062 | 0.134 | MAP kinase kinase inhibitor | |||
| 0.084 | 0.013 | 0.084 | Sphingosine kinase inhibitor | 0.057 0.046 DBMET01478 | ||
| 0.113 | 0.043 | 0.113 | Electrolyte absorption antagonist | |||
| 0.149 | 0.079 | 0.149 | Diuretic | |||
| 0.072 | 0.005 | 0.093 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.093 0.003 DBMET01478 | DBMET01478 | |
| 0.113 | 0.047 | 0.151 | Anabolic | 0.151 0.017 DBMET01478 | DBMET01478 | |
| 0.073 | 0.007 | 0.073 | HIV-1 protease inhibitor | 0.044 0.028 DBMET01478 | ||
| 0.116 | 0.05 | 0.155 | DOPA decarboxylase inhibitor | 0.155 0.019 DBMET01478 | DBMET01478 | |
| 0.119 | 0.054 | 0.119 | Falcipain 3 inhibitor | |||
| 0.099 | 0.038 | 0.254 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.254 0.006 DBMET01478 | DBMET01478 | |
| 0.078 | 0.017 | 0.078 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.068 | 0.009 | 0.275 | Fumarate hydratase inhibitor | 0.275 0.003 DBMET01478 | DBMET01478 | |
| 0.07 | 0.011 | 0.07 | Heparanase inhibitor | 0.068 0.013 DBMET01478 | ||
| 0.083 | 0.024 | 0.15 | Ribonucleoside-diphosphate reductase inhibitor | 0.15 0.011 DBMET01478 | DBMET01478 | |
| 0.084 | 0.025 | 0.163 | Ribonucleotide reductase inhibitor | 0.163 0.01 DBMET01478 | DBMET01478 | |
| 0.096 | 0.038 | 0.311 | Porphobilinogen synthase inhibitor | 0.311 0.005 DBMET01478 | DBMET01478 | |
| 0.136 | 0.079 | 0.182 | Protein kinase stimulant | 0.182 0.049 DBMET01478 | DBMET01478 | |
| 0.204 | 0.147 | 0.204 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.217 | 0.161 | 0.217 | Interleukin 2 agonist | |||
| 0.072 | 0.017 | 0.072 | Epithelial sodium channel blocker | |||
| 0.209 | 0.156 | 0.209 | Caspase 3 stimulant | |||
| 0.078 | 0.024 | 0.078 | Caspase 9 inhibitor | |||
| 0.078 | 0.025 | 0.078 | Cathepsin B inhibitor | |||
| 0.078 | 0.029 | 0.078 | Exportin-1 inhibitor | |||
| 0.052 | 0.005 | 0.052 | Calpain 1 inhibitor | 0.031 0.029 DBMET01478 | ||
| 0.076 | 0.03 | 0.15 | Glutamate (mGluR6) antagonist | 0.15 0.004 DBMET01478 | DBMET01478 | |
| 0.082 | 0.036 | 0.082 | Glycine receptor agonist | |||
| 0.057 | 0.011 | 0.057 | GABA uptake inhibitor | |||
| 0.16 | 0.115 | 0.16 | MAP kinase kinase 5 inhibitor | |||
| 0.162 | 0.117 | 0.162 | Insulin sensitizer | |||
| 0.057 | 0.013 | 0.371 | Sphingosine 1-phosphate receptor 3 agonist | 0.371 0.002 DBMET01478 | DBMET01478 | |
| 0.051 | 0.008 | 0.052 | Uridine phosphorylase inhibitor | 0.052 0.008 DBMET01478 | DBMET01478 | |
| 0.082 | 0.039 | 0.082 | GABA B receptor agonist | |||
| 0.054 | 0.013 | 0.163 | Phosphoglycerate kinase inhibitor | 0.163 0.004 DBMET01478 | DBMET01478 | |
| 0.087 | 0.046 | 0.087 | Estrogen-related receptor beta agonist | |||
| 0.162 | 0.121 | 0.162 | Neurotrophic factor enhancer | |||
| 0.056 | 0.015 | 0.069 | Guanylate cyclase inhibitor | 0.069 0.005 DBMET01478 | DBMET01478 | |
| 0.171 | 0.131 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.046 | 0.007 | 0.046 | Prostaglandin EP2 agonist | |||
| 0.134 | 0.095 | 0.281 | Phospholipase A2 inhibitor | 0.281 0.016 DBMET01478 | DBMET01478 | |
| 0.07 | 0.032 | 0.166 | Purinergic P2X1 antagonist | 0.166 0.005 DBMET01478 | DBMET01478 | |
| 0.123 | 0.084 | 0.123 | Interleukin 1 antagonist | |||
| 0.097 | 0.059 | 0.097 | Prolactin inhibitor | |||
| 0.15 | 0.115 | 0.199 | Non-steroidal antiinflammatory agent | 0.199 0.072 DBMET01478 | DBMET01478 | |
| 0.108 | 0.074 | 0.108 | TRPA1 agonist | |||
| 0.088 | 0.056 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.051 | 0.019 | 0.147 | Sphingosine 1-phosphate receptor 1 agonist | 0.147 0.004 DBMET01478 | DBMET01478 | |
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.115 | 0.083 | 0.225 | Sphingosine 1-phosphate receptor 4 antagonist | 0.225 0.005 DBMET01478 | DBMET01478 | |
| 0.056 | 0.027 | 0.157 | Lysophosphatidic acid 3 receptor antagonist | 0.157 0.003 DBMET01478 | DBMET01478 | |
| 0.052 | 0.023 | 0.052 | Toll-Like receptor 2 agonist | |||
| 0.036 | 0.007 | 0.107 | Lysophosphatidic acid receptor 1 agonist | 0.107 0.002 DBMET01478 | DBMET01478 | |
| 0.079 | 0.05 | 0.121 | Carbonic anhydrase XIII inhibitor | 0.121 0.029 DBMET01478 | DBMET01478 | |
| 0.071 | 0.044 | 0.182 | Sphingosine 1-phosphate receptor 4 agonist | 0.182 0.005 DBMET01478 | DBMET01478 | |
| 0.107 | 0.081 | 0.107 | Caspase 3 inhibitor | |||
| 0.051 | 0.026 | 0.051 | Microtubule stabilization | |||
| 0.119 | 0.096 | 0.119 | Neurotrophic factor | |||
| 0.027 | 0.003 | 0.038 | Methylmalonyl-CoA mutase inhibitor | 0.038 0.001 DBMET01478 | DBMET01478 | |
| 0.045 | 0.023 | 0.069 | Thymidine kinase inhibitor | 0.069 0.011 DBMET01478 | DBMET01478 | |
| 0.037 | 0.015 | 0.037 | Prostaglandin agonist | |||
| 0.03 | 0.009 | 0.03 | Prostaglandin F2 alpha agonist | |||
| 0.025 | 0.004 | 0.108 | Lysophosphatidic acid receptor 3 agonist | 0.108 0.001 DBMET01478 | DBMET01478 | |
| 0.19 | 0.172 | 0.19 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.155 | 0.138 | 0.244 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.244 0.045 DBMET01478 | DBMET01478 | |
| 0.097 | 0.08 | 0.097 | Cystathionine beta-synthase inhibitor | |||
| 0.048 | 0.031 | 0.102 | Thymidylate synthase inhibitor | 0.102 0.004 DBMET01478 | DBMET01478 | |
| 0.039 | 0.023 | 0.084 | Glutamate (mGluR8) agonist | 0.084 0.004 DBMET01478 | DBMET01478 | |
| 0.045 | 0.03 | 0.139 | Sphingosine 1-phosphate receptor agonist | 0.139 0.004 DBMET01478 | DBMET01478 | |
| 0.042 | 0.027 | 0.042 | Sphingosine kinase 1 inhibitor | |||
| 0.029 | 0.013 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.124 | 0.109 | 0.124 | Thiol protease inhibitor | |||
| 0.024 | 0.009 | 0.024 | Neuraminidase (Influenza B) inhibitor | |||
| 0.019 | 0.006 | 0.019 | Thromboxane A2 agonist | |||
| 0.054 | 0.041 | 0.054 | Beta 1 adrenoreceptor antagonist | |||
| 0.017 | 0.004 | 0.017 | 3C-Like protease (MERS coronavirus) inhibitor | |||
| 0.097 | 0.085 | 0.097 | Anesthetic local | |||
| 0.034 | 0.023 | 0.034 | Calcitonin receptor agonist | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | |||
| 0.053 | 0.042 | 0.06 | Sphingosine kinase 2 inhibitor | 0.06 0.031 DBMET01478 | DBMET01478 | |
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.042 | 0.033 | 0.082 | Geranyltranstransferase inhibitor | 0.082 0.005 DBMET01478 | DBMET01478 | |
| 0.019 | 0.01 | 0.019 | Ileal bile acid transport inhibitor | |||
| 0.014 | 0.005 | 0.019 | Purine nucleoside phosphorylase inhibitor | 0.019 0.004 DBMET01478 | DBMET01478 | |
| 0.035 | 0.026 | 0.035 | Antibiotic Aminoglycoside-like | 0.033 0.032 DBMET01478 | ||
| 0.071 | 0.063 | 0.071 | Vanilloid 4 agonist | |||
| 0.038 | 0.03 | 0.04 | Membrane dipeptidase inhibitor | 0.04 0.026 DBMET01478 | DBMET01478 | |
| 0.076 | 0.069 | 0.107 | Glutathione S-transferase inhibitor | 0.107 0.031 DBMET01478 | DBMET01478 | |
| 0.188 | 0.182 | 0.188 | Transcription factor NF kappa B inhibitor | |||
| 0.069 | 0.063 | 0.069 | GABA aminotransferase inhibitor | |||
| 0.033 | 0.028 | 0.033 | Renin inhibitor | |||
| 0.02 | 0.015 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.022 | 0.017 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.084 | 0.079 | 0.084 | Glutamate release inhibitor | |||
| 0.025 | 0.021 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.016 | 0.012 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.097 | 0.094 | 0.097 | Photosensitizer | |||
| 0.025 | 0.021 | 0.025 | Lysine carboxypeptidase inhibitor | |||
| 0.016 | 0.013 | 0.016 | Carbonic anhydrase X inhibitor | |||
| 0.016 | 0.013 | 0.016 | Carbonic anhydrase VIII inhibitor | |||
| 0.134 | 0.131 | 0.134 | Interleukin antagonist | |||
| 0.04 | 0.037 | 0.081 | AICAR transformylase inhibitor | 0.081 0.007 DBMET01478 | DBMET01478 | |
| 0.053 | 0.05 | 0.053 | Pregnane X receptor antagonist | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | |||
| 0.087 | 0.085 | 0.087 | Mediator release inhibitor | |||
| 0.096 | 0.093 | 0.096 | Proteasome inhibitor | |||
| 0.119 | 0.116 | 0.119 | Hemostatic | |||
| 0.045 | 0.043 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.018 | 0.016 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.047 | 0.046 | 0.047 | Cathepsin D inhibitor | |||
| 0.059 | 0.057 | 0.059 | Interferon inducer | |||
| 0.045 | 0.044 | 0.045 | Aldose reductase inhibitor | |||
| 0.02 | 0.019 | 0.02 | Vitamin D receptor antagonist | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.016 | 0.015 | 0.016 | Telomerase stimulant | |||
| 0.04 | 0.04 | 0.156 | Antimetabolite | 0.156 0.012 DBMET01478 | DBMET01478 | |
| 0.111 | 0.112 | 0.144 | Vanilloid 1 agonist | 0.144 0.044 DBMET01478 | DBMET01478 | |
| 0.013 | 0.017 | 0.026 | Purinergic P2Y1 agonist | 0.026 0.004 DBMET01478 | DBMET01478 | |
| 0.007 | 0.015 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.004 DBMET01478 | DBMET01478 | |
| 0.119 | 0.128 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | 0.205 0.009 DBMET01478 | DBMET01478 | |
| 0.098 | 0.109 | 0.514 | Bone formation stimulant | 0.514 0.005 DBMET01478 | DBMET01478 | |
| 0.007 | 0.021 | 0.024 | Glutamate (mGluR6) agonist | 0.024 0.004 DBMET01478 | DBMET01478 | |
| 0.198 | 0.217 | 0.308 | Calcium channel activator | 0.308 0.084 DBMET01478 | DBMET01478 | |
| 0.021 | 0.049 | 0.201 | Lysophosphatidic acid 2 receptor antagonist | 0.201 0.003 DBMET01478 | DBMET01478 | |
| 0.089 | 0.121 | 0.14 | Cyclooxygenase 3 inhibitor | 0.14 0.057 DBMET01478 | DBMET01478 | |
| 0.068 | 0.115 | 0.101 | D-Ala-D-Ala ligase inhibitor | 0.101 0.028 DBMET01478 | DBMET01478 | |
| 0.029 | 0.077 | 0.039 | Vanilloid 3 antagonist | 0.039 0.024 DBMET01478 | DBMET01478 | |
| 0 | 0.051 | 0.008 | Purinergic P2Y4 agonist | 0.008 0.002 DBMET01478 | DBMET01478 | |
| 0.209 | 0.261 | 0.448 | Apoptosis agonist | 0.448 0.092 DBMET01478 | DBMET01478 | |
| 0.046 | 0.101 | 0.057 | Lipocortins synthesis agonist | 0.057 0.042 DBMET01478 | DBMET01478 | |
| 0.011 | 0.073 | 0.054 | Lysophosphatidic acid 1 receptor antagonist | 0.054 0.004 DBMET01478 | DBMET01478 | |
| 0.035 | 0.102 | 0.106 | Sphingosine 1-phosphate receptor 3 antagonist | 0.106 0.007 DBMET01478 | DBMET01478 | |
| 0.067 | 0.135 | 0.158 | Adenylate cyclase inhibitor | 0.158 0.04 DBMET01478 | DBMET01478 | |
| 0.018 | 0.093 | 0.042 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.042 0.015 DBMET01478 | DBMET01478 | |
| 0.095 | 0.174 | 0.186 | Sphingosine 1-phosphate receptor 2 antagonist | 0.186 0.012 DBMET01478 | DBMET01478 | |
| 0.118 | 0.201 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.105 DBMET01478 | DBMET01478 | |
| 0.003 | 0.086 | 0.054 | Purinergic P2Y agonist | 0.054 0.002 DBMET01478 | DBMET01478 | |
| 0.003 | 0.09 | 0.064 | Purinergic receptor agonist | 0.064 0.002 DBMET01478 | DBMET01478 | |
| 0.003 | 0.09 | 0.064 | Purinergic P2 agonist | 0.064 0.002 DBMET01478 | DBMET01478 | |
| 0.063 | 0.151 | 0.365 | DNA polymerase I inhibitor | 0.365 0.007 DBMET01478 | DBMET01478 | |
| 0.084 | 0.18 | 0.483 | Sphingosine 1-phosphate receptor 2 agonist | 0.483 0.003 DBMET01478 | DBMET01478 | |
| 0.027 | 0.146 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 DBMET01478 | DBMET01478 | |
| 0.033 | 0.155 | 0.068 | Sphingosine 1-phosphate receptor 1 antagonist | 0.068 0.019 DBMET01478 | DBMET01478 | |
| 0.028 | 0.155 | 0.099 | HIV-1 integrase (3'-Processing) inhibitor | 0.099 0.026 DBMET01478 | DBMET01478 | |
| 0.022 | 0.149 | 0.094 | HIV-1 integrase (Strand Transfer) inhibitor | 0.094 0.025 DBMET01478 | DBMET01478 | |
| 0.127 | 0.255 | 0.305 | Transcription factor STAT3 inhibitor | 0.305 0.051 DBMET01478 | DBMET01478 | |
| 0.025 | 0.157 | 0.05 | Glutamate (mGluR group III) antagonist | 0.05 0.02 DBMET01478 | DBMET01478 | |
| 0.012 | 0.147 | 0.094 | Purinergic P2Y antagonist | 0.094 0.01 DBMET01478 | DBMET01478 | |
| 0.062 | 0.22 | 0.268 | Psychostimulant | 0.268 0.052 DBMET01478 | DBMET01478 | |
| 0.064 | 0.224 | 0.187 | Angiogenesis stimulant | 0.187 0.101 DBMET01478 | DBMET01478 | |
| 0.013 | 0.18 | 0.04 | Fructose-1,6-bisphosphatase inhibitor | 0.04 0.039 DBMET01478 | DBMET01478 | |
| 0.006 | 0.174 | 0.128 | Purinergic P2X agonist | 0.128 0.002 DBMET01478 | DBMET01478 | |
| 0.057 | 0.234 | 0.123 | Glutamate (mGluR7) agonist | 0.123 0.027 DBMET01478 | DBMET01478 | |
| 0.054 | 0.234 | 0.214 | Toll-Like receptor 4 antagonist | 0.214 0.005 DBMET01478 | DBMET01478 | |
| 0.019 | 0.207 | 0.205 | Purinergic P2X2 antagonist | 0.205 0.004 DBMET01478 | DBMET01478 | |
| 0.023 | 0.225 | 0.348 | Sphingosine 1-phosphate receptor 5 agonist | 0.348 0.003 DBMET01478 | DBMET01478 | |
| 0.034 | 0.252 | 0.092 | Sphingosine 1-phosphate receptor antagonist | 0.092 0.028 DBMET01478 | DBMET01478 | |
| 0.086 | 0.364 | 0.274 | Transcription factor STAT inhibitor | 0.274 0.071 DBMET01478 | DBMET01478 | |
| 0.004 | 0.284 | 0.031 | Squalene synthetase inhibitor | 0.031 0.023 DBMET01478 | DBMET01478 | |
| 0.028 | 0.324 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 DBMET01478 | DBMET01478 | |
| 0.005 | 0.305 | 0.024 | Purinergic P2Y12 antagonist | 0.024 0.015 DBMET01478 | DBMET01478 | |
| 0.037 | 0.337 | 0.117 | Beta amyloid protein antagonist | 0.117 0.07 DBMET01478 | DBMET01478 | |
| 0.013 | 0.334 | 0.069 | Toll-Like receptor 4 agonist | 0.069 0.003 DBMET01478 | DBMET01478 | |
| 0.022 | 0.419 | 0.288 | Aminoacyl-tRNA synthetase inhibitor | 0.288 0.007 DBMET01478 | DBMET01478 | |
| 0.036 | 0.441 | 0.174 | Platelet antagonist | 0.174 0.122 DBMET01478 | DBMET01478 | |
| 0.01 | 0.458 | 0.066 | CDC25A inhibitor | 0.066 0.064 DBMET01478 | DBMET01478 | |
| 0.004 | 0.512 | 0.048 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.048 0.005 DBMET01478 | DBMET01478 | |
| 0.038 | 0.602 | 0.22 | Folate antagonist | 0.22 0.007 DBMET01478 | DBMET01478 | |
| 0.003 | 0.788 | 0.031 | Urotensin II agonist | 0.031 0.015 DBMET01478 | DBMET01478 | |
| 0.007 | 0.828 | 0.146 | Purinergic P2Y2 antagonist | 0.146 0.003 DBMET01478 | DBMET01478 | |
| 0.004 | 0.859 | 0.052 | Growth factor receptor-bound protein 2 antagonist | 0.052 0.004 DBMET01478 | DBMET01478 | |
| 0.006 | 0.899 | 0.295 | Autotaxin inhibitor | 0.295 0.004 DBMET01478 | DBMET01478 | |
| 0.02 | 0.934 | 0.146 | Catenin beta inhibitor | 0.146 0.115 DBMET01478 | DBMET01478 | |
| 0.005 | 0.931 | 0.154 | Antimitotic | 0.154 0.118 DBMET01478 | DBMET01478 | |
| 0.003 | 0.947 | 0.082 | Purinergic P2 antagonist | 0.082 0.031 DBMET01478 | DBMET01478 | |
| 0.001 | 0.993 | 0.082 | Purinergic P2Y1 antagonist | 0.082 0.003 DBMET01478 | DBMET01478 | |
| 0.003 | 0.996 | 0.094 | DNA directed RNA polymerase inhibitor | 0.094 0.063 DBMET01478 | DBMET01478 | |
| 0.002 | 0.996 | 0.055 | Potassium channel (Ca-activated) blocker | 0.055 0.052 DBMET01478 | DBMET01478 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |